Albemarle Corporation requests shareholder votes at its May 5, 2026 Annual Meeting and presents its 2026 proxy and 2025 Annual Report. The company reports $5.1 billion in 2025 net sales and $1.1 billion adjusted EBITDA, with 7% volume growth and $1.3 billion operating cash flow (an 86% increase year-over-year). The proxy includes management proposals to elect ten directors, ratify PwC as auditor, remove remaining supermajority charter provisions, and approve the 2026 Incentive Plan. The Board added two independent directors and discloses proceeds from strategic portfolio actions, including a $350 million customer prepayment, a $307.4 million redemption, and combined pre-tax divestiture proceeds of approximately $670 million received at close in March 2026. Voting is for shareholders of record as of March 11, 2026.
ALBEMARLE CORP director Alejandro Daniel Wolff increased his stake through automatic dividend reinvestment. On January 2, 2026, he acquired 32 shares of common stock at a stated price of $0.00 per share, bringing his directly held position to 12,986 shares.
The Form 4 also reports earlier dividend reinvestment acquisitions of 46 shares on October 1, 2024, 42 shares on July 1, 2024, 32 shares on April 2, 2024, 29 shares on January 3, 2024, and 25 shares on October 3, 2023. All transactions are described as dividends acquired under an automatic dividend reinvestment program, indicating routine, compensation-like share accumulations rather than open‑market purchases.
Albemarle Corporation reported a Form 144 notice to sell 11,783 shares. The filing lists Goldman Sachs & Co. LLC as the broker and an aggregate amount of $1,962,340.82. The securities were acquired as compensation (Restricted Stock Units) on 02/26/2026, 02/18/2022, and 05/05/2023, with per‑lot quantities of 5,108, 3,568, and 3,107 shares respectively.
Albemarle Corporation has completed the sale of its 51% ownership interest in Ketjen Corporation to an affiliate of KPS Capital Partners, while retaining a 49% minority stake. Albemarle expects approximately $547 million in cash from the Ketjen sale, including $22 million of cash held by Ketjen.
Combined with the earlier sale of its 50% interest in the Eurecat joint venture to Axens SA, Albemarle’s pre-tax proceeds from the two transactions total about $670 million. The company plans to use these funds for debt reduction, including cash tender offers of up to $500 million for several series of senior notes and the full redemption of $650,000,000 of 4.650% Senior Notes due 2027.
Sheorey Neal Ravi reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation’s Chief Financial Officer, Neal Ravi Sheorey, received an equity award of 4,490 shares in the form of restricted stock units at a grant price of $0 per share. These units vest 100% on 03/02/2029, subject to the terms of the applicable award agreement.
The filing also updates his reported holdings to a total of 20,931 shares after the transaction. This amount now includes 4,231 unvested restricted stock units that vest 100% on 02/22/2027, which are being reported as beneficially owned common stock to align reporting methodology among Albemarle insiders.
Norris Eric reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation reported that Chief Commercial Officer Eric Norris received a grant of 4,490 restricted stock units on March 2, 2026. The award has no purchase price and will vest 100% on March 2, 2029, subject to the terms of the award agreement. Following this grant, Norris beneficially owns 53,443 shares of Albemarle common stock directly.
LaBauve Donald J. Jr. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation executive Donald J. LaBauve Jr., VP, Corporate Controller & CAO, received an award of 698 shares of Common Stock on a grant/award basis at $0.00 per share. Following this award, his directly held Common Stock totaled 10,402 shares.
A related footnote explains that these are restricted stock units that vest 100% on March 2, 2029, subject to the award agreement. He also reported 12,755 shares of Common Stock held indirectly through the Albemarle Corporation Retirement Savings Plan.
Krupa Ander C. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corp reported that its General Counsel & Secretary, Ander C. Krupa, was granted 1,796 restricted stock units on March 2, 2026. According to the award terms, these restricted stock units vest 100% on March 2, 2029, increasing the officer’s directly held common stock-related interest to 13,184 shares after the award.
Mummert Mark Richard reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corp’s Chief Supply Chain Officer, Mark Richard Mummert, received an equity award of 3,143 shares of common stock on 03/02/2026. The award is in the form of Restricted Stock Units that vest 100% on 03/02/2029, subject to the terms of the award agreement. Following this grant, his directly owned common stock holdings total 17,515 shares.
Albemarle Corporation’s Chairman and CEO J Kent Masters reported an equity award. He acquired 22,450 shares in the form of restricted stock units granted at no cash cost, which vest 100% on 03/30/2027. Following this grant, he beneficially owns 146,411 common shares directly.